AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MEMPHASYS LIMITED. Capital/Financing Update 2016

Apr 11, 2016

65314_rns_2016-04-11_af732d69-005f-40cd-a5f1-e93e98a20a42.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [196 x 96] intentionally omitted <==

ASX Release

SALE OF NUSEP’S GELS BUSINESS

Sydney, Tuesday 12 April 2016

NuSep Holdings Limited ( ASX: NSP ) (“ NuSep ”) advises that it has sold its US subsidiary, NuSep, Inc. and its Gels Business including the manufacturing plant and all related patents to Dycent Biotech (Shanghai) Co. Ltd for US$130,000. In addition, Dycent placed a substantial order with NuSep to manufacture gels to provide sufficient stocks for the business during the transfer of the plant to Shanghai.

The manufacturing plant will be moved to Shanghai where Dycent will continue to manufacture nUView gels.

The sale of the Gels Business allows NuSep to focus on developing its in-house assets with high IP value, in particular SpermSep, NuSep’s patented technology for sperm processing for use in assisted reproductive technologies.

For further information please contact:

Alison Coutts Executive Chairman +61 2 8415 7300 [email protected]

NuSep Holdings Ltd 30 Richmond Rd Homebush NSW 2140